The Alzheimer’s Disease Diagnostic Market share is dominated by major healthcare and diagnostic companies such as Roche, Eli Lilly, and GE Healthcare. Their advanced technologies and global presence strengthen their position. Smaller biotech startups are also gaining share by offering niche, cost-effective solutions. This growing competition enhances innovation and accessibility. FAQsQ1....